![]() | ![]() |
Formats:
|
||||||||||||
Copyright © 2006, Cold Spring Harbor Laboratory Press
Tsix-mediated epigenetic switch of a CTCF-flanked region of the Xist promoter determines the Xist transcription program Unité de Génétique Moléculaire Murine, Institut Pasteur 75724, Paris Cedex 15, France 1Corresponding author. E-MAIL rougeull/at/pasteur.fr; FAX 33-1-45-68-8656. Received March 30, 2006; Accepted August 17, 2006. This article has been cited by other articles in PMC.Abstract Initiation of X inactivation depends on the coordinated expression of the sense/antisense pair Xist/Tsix. We show here that a precisely defined Xist promoter region flanked by CTCF is maintained by Tsix in a heterochromatic-like state in undifferentiated embryonic stem (ES) cells and shifts to a pseudoeuchromatic structure upon Tsix truncation. We further demonstrate that the epigenetic state of the Xist 5′ region prior to differentiation predicts the efficiency of transcriptional machinery recruitment to the Xist promoter during differentiation. Our results provide mechanistic insights into the Tsix-mediated epigenetic regulation of Xist resulting in Xist promoter activation and initiation of X inactivation in differentiating ES cells. Keywords: X inactivation, chromatin modifications, CTCF boundaries, noncoding RNA, antisense transcription, epigenetic regulation Histone modifications participate in the establishment of local chromatin structures that, in particular, render gene promoter permissive or not for the subsequent assembly and/or activation of the transcriptional machinery (Mellor 2005). Among such marks, covalent modifications of Lys 4, Lys 9, and Lys 27 of the histone H3 tail (H3K4, H3K9, and H3K27, respectively) are known to play crucial roles. H3K4 methylation and H3K9 acetylation have been extensively associated with active regions of the genome (euchromatin) while H3K9 and K27 methylation participate in the establishment and maintenance of silent domains (heterochromatin). The relationship between euchromatin and heterochromatin, dictated in part by covalent modifications of histones but also of CpG sites on DNA (Jaenisch and Bird 2003), provides an elegant support for the information required to establish heritable epigenetic states of gene expression programs during development (Turner 2002; Rasmussen 2003). One of the most relevant paradigms for such epigenetic regulation is provided by X inactivation, in which a single X chromosome is randomly chosen in females to be transcriptionally silenced at the onset of epiblast differentiation. Once established, this silent state is inherited through cell division and lineage commitment. Initiation of X inactivation depends on the noncoding Xist RNA, which coats the X chromosome in cis and induces gene silencing and heterochromatin formation (Heard 2005). The regulation of Xist expression is therefore an essential event of the X-inactivation process, thought to involve both post-transcriptional (Panning et al. 1997; Sheardown et al. 1997; Ciaudo et al. 2006) and transcriptional (Navarro et al. 2005; Sun et al. 2006) mechanisms. Embryonic stem (ES) cells recapitulate random X inactivation at the onset of cell differentiation and have proved an excellent model for the study of this epigenetic process (Chaumeil et al. 2002). In undifferentiated female ES cells, both X chromosomes transcribe low levels of Xist RNA. As the cell differentiates, one Xist allele per diploid set of autosomes is up-regulated, inducing X inactivation in cis, while the second Xist allele of females and the single Xist allele of males are turned off. An intriguing characteristic of the Xist gene is its complete overlapping by a noncoding antisense transcription unit, Tsix, which represses Xist RNA accumulation in cis (Ogawa and Lee 2002; Rougeulle and Avner 2004). Studies of Tsix mutations in both female (Debrand et al. 1999; Lee and Lu 1999; Luikenhuis et al. 2001) and male (Morey et al. 2004; Vigneau et al. 2006) ES cells indicate that an X chromosome in which Tsix transcription has been disrupted systematically up-regulates Xist expression at the onset of ES cell differentiation, whether in male or female ES cells. This indicates that Tsix ensures the randomness of Xist up-regulation in females and programs Xist for silencing in males. In agreement with this, insertion of an inducible promoter to force Tsix expression during female ES cell differentiation abolishes the possibility of the mutated allele to up-regulate Xist (Stavropoulos et al. 2001). Tsix therefore determines the potential of Xist to be up-regulated at the onset of differentiation. Recently, we and others have shown that Tsix has complex chromatin remodeling activities within the Xist/Tsix locus. Tsix triggers H3K4 dimethylation within the overall locus but represses increased accumulation across the Xist promoter (Navarro et al. 2005). In addition, male mouse embryonic fibroblasts (MEFs, which in contrast to females do not express Xist) derived from Tsix mutants show aberrant chromatin conformation at the Xist promoter, characterized in particular by high levels of H3K4 dimethylation (Sado et al. 2005). Given (1) the dramatic effect that Tsix abolishment has both on Xist chromatin modification and expression levels and (2) the involvement of chromatin conformation in the establishment and maintenance of specific gene expression programs during differentiation, we hypothesized that Tsix regulation may induce different epigenetic states at the Xist promoter on the future inactive and active X chromosomes to determine Xist expression programs. Our analysis exploiting wild-type and Tsix-truncated ES cells demonstrates that Tsix represses the euchromatinization of a CTCF-flanked region of the Xist promoter, precluding transcriptional Xist up-regulation during differentiation. In contrast, Tsix truncation generates a stable pseudoeuchromatic state at the Xist 5′ region that preempts transcription apparatus assembly at the Xist promoter and initiation of X inactivation. These conclusions are in striking contrast to those of a recent study (Sun et al. 2006), where it was suggested that down-regulation of Tsix induces a heterochromatic state at Xist, paradoxically followed by transcriptional activation of Xist. Results and Discussion Tsix triggers H3K9 trimethylation and DNA methylation to the Xist 5′ region Antisense transcription across the Xist promoter was previously shown to repress increased levels of H3K4 dimethylation around this specific region (Navarro et al. 2005). In order to map precisely the region affected and to assess whether other epigenetic marks are similarly controlled by Tsix, we have undertaken a systematic analysis of the Xist promoter region (Fig. 1A
Strikingly, the gain of the three active marks tested in the mutant was accompanied by the virtually complete loss of H3K9 trimethylation around the Xist 5′ region (Fig. 1E Our results indicate that, in ES cells, Tsix blocks the euchromatinization of the Xist 5′ region by triggering negative epigenetic marks, possibly through a mechanism similar to that used by Xist RNA to induce X-chromosome-wide heterochromatinization (Bernstein and Allis 2005), involving the recruitment of repressive enzymatic complexes to the Xist 5′ region (such as H3K9 and DNA methyltransferases together with histone deacetylases and/or H3K4 demethylases). The recent finding of biochemical interaction between Dnmt3a, a de novo DNA methyltransferase, and Tsix RNA (Sun et al. 2006) supports this idea. Global euchromatic effects of Tsix transcription on chromatin conformation of the Xist/Tsix locus In the overall Xist/Tsix locus, the effect of Tsix on H3K4 dimethylation was shown to be distinct from its effect at the Xist promoter (Navarro et al. 2005). It was tempting to speculate that similar regulation would apply to the other modifications controlled by Tsix within the Xist 5′ region. To address this specific issue, additional positions upstream of and downstream from the inserted transcriptional stop signal were analyzed by chromatin immunoprecipitation (ChIP) (Fig. 2A
In addition, the high levels of H3K9 trimethylation that are detected across the overall Xist/Tsix locus with the exception of the Tsix promoter (Fig. 2E We conclude that among the histone marks analyzed, H3K4 dimethylation (Fig. 2B CTCF as a candidate protein to constrain the repressive epigenetic effects mediated by Tsix to the Xist 5′ region exclusively We have demonstrated that Tsix oppositely affects the Xist 5′ region and the overall Tsix transcription unit. This suggests that an insulation of the Xist 5′ region, capable of limiting the spreading of H3K9 trimethylation and/or CpG methylation to the overall Xist/Tsix region, may be occurring. Importantly, the region showing variation of chromatin modification levels appears to be precisely defined and restricted to the −1- to +1.5-kb interval of the Xist promoter region (Fig. 3A
In mammals, CTCF has been shown to be able to insulate specific regions of the genome and to define distinct chromatin domains. CTCF binds to regions of transition between X-inactivated genes and genes escaping X inactivation (Filippova et al. 2005) and acts at the CTG repeats of the DM1 locus to constrain H3K9 methylation and prevent its spreading (Cho et al. 2005). Like the CTG repeats at the DM1 locus, the Xist 5′ region can be viewed as an island of negative epigenetic marks embedded within a region of euchromatin-associated histone modifications. We therefore searched for CTCF binding on both sides of the −1- to +1.5-kb interval. Using two independent antibodies against CTCF (Supplementary Fig. 2A,B), we were able to immunoprecipitate CTCF at the predicted positions in both undifferentiated female (Fig. 3B The binding profile of CTCF was found to be altered in Tsix-truncated cells (Fig. 3C Tsix truncation leads to inappropriate transcriptional up-regulation of Xist in differentiated male ES cells In undifferentiated ES cells, Xist expression is significantly down-regulated through repression of the transcription machinery assembly at the Xist P1 promoter (Navarro et al. 2005). This correlates with the finding that Tsix induces, across this specific region, the accumulation of epigenetic marks associated with inactive chromatin and represses the enrichment for active histone modifications. The truncation of Tsix, which completely remodels the chromatin architecture of the CTCF-flanked Xist 5′ region (Fig. 1 To test this hypothesis, wild-type and mutant male ES cells were induced to differentiate and levels of RNA Polymerase II and TFIIB (Fig. 4A
In striking contrast, RNA Polymerase II and TFIIB binding to P1 were significantly increased after 4 d of differentiation in Tsix-truncated cells (Fig. 4A Conclusions We demonstrate here that Tsix induces a number of epigenetic marks within the Xist/Tsix region, which result in a CTCF-flanked Xist 5′ region enriched for H3K9 trimethylation and DNA methylation, embedded within a larger euchromatic domain enriched for H3K4 dimethylation and protected from H3K27 trimethylation. Under these conditions, male ES cells are unable to transcriptionally up-regulate the Xist promoter at the onset of differentiation. In contrast, Tsix truncation leads to elevated H3K4 di/trimethylation and H3K9 acetylation at the Xist 5′ region prior to cell differentiation. Strikingly, under this primed state for activation, Tsix-truncated male ES cells efficiently up-regulate Xist transcription through stimulation of PIC recruitment to the Xist P1 promoter during differentiation, with concomitant ectopic X inactivation (Vigneau et al. 2006). It therefore appears that the chromatin modifications induced by Tsix over the Xist promoter are sufficient to determine the transcriptional fate of Xist at the onset of cell differentiation. We conclude that Tsix mediates the counting process of X inactivation, which precludes high Xist up-regulation in males, through the epigenetic repression of the Xist promoter. This study has further consequences for our understanding of X-inactivation regulation in female ES cells, where Tsix is repressed first on the future inactive X (Lee et al. 1999). In this context, the initial monoallelic Tsix repression in a specific time window of differentiation will induce the establishment of a euchromatic architecture at a single Xist promoter region, allowing monoallelic PIC recruitment and participating to monoallelic Xist RNA up-regulation and X inactivation. We propose that asymmetric Tsix silencing, which might be regulated through the activity of Tsix control regions (Stavropoulos et al. 2005), achieves choice through the epigenetic activation of a single Xist promoter. On the second Xist promoter in female and on the single X in male cells, the repressive chromatin conformation, initially maintained by continuous transcription of Tsix, is subsequently propagated by Tsix-independent mechanisms. This is supported by the fact that in male MEFs, the inactive Xist promoter is devoid of active histone marks although Tsix is silenced (Supplementary Fig. 3). Our findings demonstrate a crucial role for Tsix in programming the Xist expression pattern through modifications of chromatin structure of a precise CTCF-flanked Xist 5′ region. These results illustrate the extraordinary epigenetic potential of noncoding antisense transcription units, whose number in the genome is surprisingly higher than previously thought (Kiyosawa et al. 2003; Numata et al. 2003). Interestingly, recruitment of repressive histone marks by an antisense RNA has also been suggested to occur in the imprinted cluster on mouse chromosome 7 (Lewis et al. 2004; Umlauf et al. 2004). Whether other antisense transcription units epigenetically control the expression of their sense counterpart through histone and DNA modifications will be key to our understanding of the epigenome regulation. Materials and methods Cell culture Cells were cultured and differentiated as previously described (Navarro et al. 2005; Vigneau et al. 2006). Chromatin and RNA of undifferentiated and differentiated Ma1L and Ma2L cell lines were prepared and analyzed in parallel. ChIP ChIP assays were performed as described (Navarro et al. 2005) with the exception of sonication, which was performed using a Bioruptor (Diagenode) according to the manufacturer's instructions. Ten micrograms to 20 μg of chromatin were used for each immunoprecipitation. The following antibodies were used at the indicated dilutions: TFIIB (1/50; Santa Cruz Biotechnology), CTCF (1/50; Santa Cruz Biotechnology), RNAPolII (1/500; Euromedex), H3 di-meK4 (1/100; Upstate Biotechnology), tri-meK9 (1/100; Upstate Biotechnology), tri-meK27 (1/500; Upstate Biotechnology), and tri-meK4 (1/250; Abcam). Methyl-CpG DNA immunoprecipitation (MeDIP) MeDIP assay was performed as described (Weber et al. 2005). Briefly, genomic DNA from unfixed cells was fragmented by sonication, and 4 μg of denatured DNA were incubated with 10 μL of monoclonal antibody against 5-methylcytidine (Eurogentec) in MeDIP buffer (10 mM Na-phosphate at pH 7, 0.14 M NaCl, 0.05% Triton X-100) for 2 h with overhead shaking at 4°C. Immunocomplexes were recovered using protein G-Sepharose beads (Sigma) and washed three times with 1 mL of MeDIP buffer. The immunoprecipitated DNA was eluted in 250 μL elution buffer (50 mM TrisHCl at pH 8, 10 mM EDTA, 1% SDS) for 15 min at 65°C. After proteinase K (Eurobio) treatment, the immunoprecipitated DNA was phenol/chloroform-extracted and ethanol-precipitated. DNA pellets were resuspended in 60 μL of H2O and 5 μL were used for realtime PCR quantification Real-time PCR analysis of ChIP and MeDIP assays The immunoprecipitated DNA and a 1/100 dilution of the input DNA were analyzed by real-time PCR using SYBR Green Universal Mix and an ABI Prism 7700 (Perkin-Elmer Applied Biosystems) as previously described (Navarro et al. 2005). Quantitative RT–PCR Random-primed RT was performed at 42°C with SuperScript II reverse transcriptase (Invitrogen) using 4 μg of DNAse-treated (Roche) RNA isolated from cell cultures with RNable (Eurobio). Control reactions lacking enzyme were verified negative. We used Arpo P0 transcript levels to normalize between samples. All the primer sequences are provided as Supplementary Figure 4. ACKNOWLEDGMENTS We thank Ken Zaret and Marc Lalande for critical reading of the manuscript, Dirk Schübeler for the MeDIP protocol, and Dmitry Loukinov and Victor Lobanenkov for the kind gift of anti-CTCF 9-Mabs mix. This work was supported by the Epigenome Network of Excellence, the French Ministry of Research under the Action Concertée Incitative (contract no. 032526), and the Agence Nationale pour la Recherche (ANR, contract no. 05-JCJC-0166-01). C.R and P.A are supported by the CNRS. D.R.P. was supported by successive fellowships from the European Molecular Biology Organization (ALTF 550-2004) and the Swiss National Science Foundation (PBZHA-108411). Footnotes Supplemental material is available at http://www.genesdev.org. Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.389006. REFERENCES
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||
Mol Cell. 2005 Jul 22; 19(2):147-57.
[Mol Cell. 2005]Nat Genet. 2003 Mar; 33 Suppl():245-54.
[Nat Genet. 2003]Cell. 2002 Nov 1; 111(3):285-91.
[Cell. 2002]Reprod Biol Endocrinol. 2003 Nov 13; 1():100.
[Reprod Biol Endocrinol. 2003]Curr Opin Genet Dev. 2005 Oct; 15(5):482-9.
[Curr Opin Genet Dev. 2005]Cell. 1997 Sep 5; 90(5):907-16.
[Cell. 1997]Cell. 1997 Oct 3; 91(1):99-107.
[Cell. 1997]PLoS Genet. 2006 Jun; 2(6):e94.
[PLoS Genet. 2006]Genes Dev. 2005 Jun 15; 19(12):1474-84.
[Genes Dev. 2005]Cytogenet Genome Res. 2002; 99(1-4):59-65.
[Cytogenet Genome Res. 2002]Curr Top Dev Biol. 2004; 63():61-89.
[Curr Top Dev Biol. 2004]Mol Cell Biol. 1999 Dec; 19(12):8513-25.
[Mol Cell Biol. 1999]Cell. 1999 Oct 1; 99(1):47-57.
[Cell. 1999]Mol Cell Biol. 2001 Dec; 21(24):8512-20.
[Mol Cell Biol. 2001]Genes Dev. 2005 Jun 15; 19(12):1474-84.
[Genes Dev. 2005]Dev Cell. 2005 Jul; 9(1):159-65.
[Dev Cell. 2005]Mol Cell. 2006 Mar 3; 21(5):617-28.
[Mol Cell. 2006]Genes Dev. 2005 Jun 15; 19(12):1474-84.
[Genes Dev. 2005]Mol Cell Biol. 2001 Dec; 21(24):8512-20.
[Mol Cell Biol. 2001]Mol Cell. 2006 Mar 3; 21(5):617-28.
[Mol Cell. 2006]Dev Dyn. 1996 Apr; 205(4):421-34.
[Dev Dyn. 1996]Genes Dev. 2005 Jul 15; 19(14):1635-55.
[Genes Dev. 2005]Mol Cell. 2006 Mar 3; 21(5):617-28.
[Mol Cell. 2006]Genes Dev. 2005 Jun 15; 19(12):1474-84.
[Genes Dev. 2005]Cell. 2001 Dec 14; 107(6):727-38.
[Cell. 2001]Mol Cell Biol. 2004 Jun; 24(12):5475-84.
[Mol Cell Biol. 2004]Mol Cell. 2005 Aug 5; 19(3):381-91.
[Mol Cell. 2005]Mol Cell. 2006 Mar 3; 21(5):617-28.
[Mol Cell. 2006]Dev Cell. 2005 Jan; 8(1):31-42.
[Dev Cell. 2005]Mol Cell. 2005 Nov 11; 20(3):483-9.
[Mol Cell. 2005]Genes Dev. 2005 Jun 15; 19(12):1474-84.
[Genes Dev. 2005]Mol Cell. 2006 Mar 3; 21(5):617-28.
[Mol Cell. 2006]Cell. 2006 Apr 21; 125(2):315-26.
[Cell. 2006]Proc Natl Acad Sci U S A. 2006 May 9; 103(19):7390-5.
[Proc Natl Acad Sci U S A. 2006]Nat Genet. 1999 Apr; 21(4):400-4.
[Nat Genet. 1999]Genes Dev. 2005 Jun 15; 19(12):1474-84.
[Genes Dev. 2005]Proc Natl Acad Sci U S A. 2006 May 9; 103(19):7390-5.
[Proc Natl Acad Sci U S A. 2006]Proc Natl Acad Sci U S A. 2006 May 9; 103(19):7390-5.
[Proc Natl Acad Sci U S A. 2006]Nat Genet. 1999 Apr; 21(4):400-4.
[Nat Genet. 1999]Mol Cell Biol. 2005 Apr; 25(7):2757-69.
[Mol Cell Biol. 2005]Genome Res. 2003 Jun; 13(6B):1324-34.
[Genome Res. 2003]Genome Res. 2003 Jun; 13(6B):1301-6.
[Genome Res. 2003]Nat Genet. 2004 Dec; 36(12):1291-5.
[Nat Genet. 2004]Nat Genet. 2004 Dec; 36(12):1296-300.
[Nat Genet. 2004]Genes Dev. 2005 Jun 15; 19(12):1474-84.
[Genes Dev. 2005]Proc Natl Acad Sci U S A. 2006 May 9; 103(19):7390-5.
[Proc Natl Acad Sci U S A. 2006]Genes Dev. 2005 Jun 15; 19(12):1474-84.
[Genes Dev. 2005]Nat Genet. 2005 Aug; 37(8):853-62.
[Nat Genet. 2005]Genes Dev. 2005 Jun 15; 19(12):1474-84.
[Genes Dev. 2005]Mol Cell Biol. 2004 Jun; 24(12):5475-84.
[Mol Cell Biol. 2004]